Abstract
Aim The most common complications of diabetes mellitus are peripheral neuropathy, nephropathy, retinopathy, coronary artery disease and cerebrovascular disease. Diabetic dyslipidemia usually includes elevated triglycerides (TG), elevated low-density lipoproteins (LDL) and decreased high-density lipoproteins (HDL) levels. The objective of the study was to investigate the pattern of dyslipidemia patients of type
2 diabetes mellitus (T2DM) attending Sub District Hospital Hiranagar, District Kathua, Jammu & Kashmir State.Materials and Methods A cross-sectional study was conducted during 3 months period from September 2017 to November 2017, with the patients of type 1 diabetes mellitus, coronary heart disease and those on lipid-lowering drugs excluded from the study. The
demographic parameters (age, gender) of the patients were recorded. Fasting blood samples of the patients were taken to measure serum lipid profile parameters.Results Out of 500 patients of T2DM, 209 were males and 291 were females. The mean age of the study population was 53.5 ± 12.0 years, with the mean duration of diabetes since diagnosis being 5.2 ± 3.34 years. Out of the total, 55.6% (278) were having high s
erum triglyceride and an even higher no of patients 60.4% (302) were having raised LDL-cholesterol levels.Conclusion There is an increasing trend of diabetes and dyslipidemia in rural population with a relatively high prevalence amongst rural women and distributed equally amongst all age groups. It is advisable to go for aggressive lifestyle changes followed by medication with lipid-lowering drug. The optimal care of diabetic patients should include regular monitoring of blood sugar and full range serum lipid profile.
Keywords
References
Abou-seif MA, Youssef AA. Evaluation of some biochemical changes in diabetic patients. Clin Chim Acta. 2004;346:161–170.
Taskinen MR. Diabetic dyslipidemia. Atheroscler Suppl. 2002;3:47–51.
Mooradian AD. Dyslipidemia in type 2 diabetes mellitus. Nat Clin Pract Endocrinol Metab. 2009;5:150–159.
Mahato RV, Gyawali P, Raut PP, Regmi P, Singh KP, Pandeya DR et al. Association between glycaemic control and serum lipid profile in type 2 diabetic patients: Glycated haemoglobin as a dual biomarker. Biomed Res. 2011;22:375–380.
Uttra KM, Devrajani BR, Shah SZA, Devrajani T, Das T, Raza S, et al. Lipid profile of patients with diabetes mellitus (a multidisciplinary study). World Appl Sci J. 2011;12:1382–1384.
Anjana RM, Pradeepa R, Deepa M, Datta M, Sudha V, Unnikrishnan R et al. Prevalence of diabetes and prediabetes (impaired fasting glucose and/or impaired glucose tolerance) in urban and rural India: Phase I results of the Indian Council of Medical Research-INdia DIABetes (ICMR INDIAB) study. Diabetologia. 2011;54:3022–3027.
O’Brien T, Nguyen TT, Zimmerman BR. Hyperlipidemia and diabetes mellitus. Mayo Clin Proc. 1998;73:969–976.
Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. 2002;106:3143–3421
Ethnicity and cardiovascular disease. The incidence of myocardial infarction in white, South Asian and Afro-Caribbean patients with type 2 diabetes (U.K. Prospective Diabetes Study 32). Diabetes Care. 1998;21:1271–1277.
Hachem SB, Mooradian AD. Familial dyslipidemia: an overview of genetics, pathophysiology and management. Drugs.2006;66:1949–1969.
Refbacks
- There are currently no refbacks.
Copyright (c) 2018 Journal of Pharmaceutical and Biomedical Sciences
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.